Delivery Order SPE2DB22D3301-SPE2DB23FZ4GG

Award Date 8/30/23
Potential Completion Date 8/31/23
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $1,258.53 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 tablets of the 4 mg ondansetron orally disintegrating tablets. The contract has a period of performance from July 14, 2023 through July 17, 2023 with place of performance in Conshohocken, Pennsylvania. This delivery order was issued against an existing prime vendor contract vehicle to supply pharmaceutical products in support of the Department of Defense's medical...
The Defense Logistics Agency awarded a $3,883.91 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 packages of the 4 mg ondansetron orally disintegrating tablets. The prime contractor will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 8, 2023 to support the Department of Defense's medical supply needs. No subcontractors or set aside designations were identified. The delivery order was issued under an existing...
The Defense Logistics Agency awarded a $45,104.46 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30-count packages of 4 mg ondansetron orally disintegrating tablets. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order period of performance is September 12-13, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order supports DLA's mission to provide logistics support for...
The Defense Logistics Agency Troop Support Medical awarded a $4,877 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 packages of the 4 mg ondansetron orally disintegrating tablets. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The delivery order has a period of performance from July 22, 2023 through July 24, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support in procurement and supply...
The Defense Logistics Agency awarded a $8,363.58 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 packages of the 4 mg ondansetron orally disintegrating tablets. This order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products to various Department of Defense customers. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania by July 24, 2023 to support the logistical needs of the Defense...
The Defense Logistics Agency awarded a $1,419.79 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 tablets of the 4 mg ondansetron orally disintegrating tablet. This order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products to DLA and the Department of Defense. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by August 4, 2023. No subcontractors or set aside designations were identified....
The Defense Logistics Agency awarded a $1,470 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 packages of the 4 mg ondansetron orally disintegrating tablets. The place of performance for this single-day contract is Amerisourcebergen's facility in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing indefinite-delivery/indefinite-quantity contract vehicle....
The Defense Logistics Agency awarded a $6,221.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4,562 units of 8 mg ondansetron orally disintegrating tablets. The order was placed under an existing prime vendor contract vehicle to support the DLA's pharmaceutical distribution requirements. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day, from September 11-12, 2023. No subcontractors or set...
The Defense Logistics Agency awarded a $1,041.36 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4,562 boxes containing 255,509 units of 8 mg ondansetron orally disintegrating tablets. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The order is for product delivery between September 20-21, 2023. No major subcontractors or set aside designations were indicated. This order supports the Defense Logistics Agency's...
The Defense Logistics Agency awarded a $4,055.15 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 boxes of 4 mg ondansetron orally disintegrating tablets. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to Department of Defense customers. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of four days from July 21 to July 24, 2023. No subcontractors...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB23FZ4GG
    Delivery Order

The Defense Logistics Agency awarded a $1,292 delivery order to Amerisourcebergen Drug Corporation for 30 packages of the 4 mg ondansetron orally disintegrating tablets. This firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and will provide pharmaceutical products to support DLA and Department of Defense requirements. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period concluding on August 31, 2023. No set aside provisions or subcontracting arrangements were identified. This order represents a small pharmaceutical procurement to support the military's health and readiness missions.

Generated 12/24/23, 3:29 PM